Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anastrozole in Premenopausal Breast Cancer with Chemotherapy-Induced Ovarian Failure
NCT00555477Phase 2Terminated
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Aug 2007
- Primary completion
- Dec 2011
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anastrozole in breast cancer, sponsored by University of Michigan Rogel Cancer Center. Started Aug 2007; status: terminated.
02
Drugs
anastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00555477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00555477.